[Differences in pathological features of histological inflammation between benign prostatic hyperplasia and prostate cancer]
- PMID: 24325107
[Differences in pathological features of histological inflammation between benign prostatic hyperplasia and prostate cancer]
Abstract
Objective: To study the pathologic features and differences of tissue inflammation in benign prostatic hyperplasia (BPH) and prostate cancer (PCa).
Methods: The HE stained slice obtained by prostate biopsy from 143 BPH and 106 PCa were reviewed to determine whether the tissue inflammation existed. According to the histological classification of prostatic tissue inflammation, the features of tissue inflammation and the differences of these features between the two groups were studied in detail.
Results: There were 142 cases found tissue inflammation in 143 BPH patients and 104 cases in 106 PCa patients, so the incidences of tissue inflammation in BPH and PCa were 99. 3% and 98. 1% respectively. The anatomical location of inflammation was significant difference between BPH and PCa group (P<0. 05). The peri-glandular inflammation (56. 3%) was primary in BPH, and interstitial inflammation (56.7%) was the main pattern in PCa. The inflammation range was also significant difference between the two groups (P<0. 05). The inflammation was presented multifocally (60. 6%) in BPH, and focal lesions (51. 0%) was commonly found in PCa. Mild inflammation was most frequently observed in both groups (P>0. 05). However, there were statistically significant differences between the two groups in the degree of moderate and severe inflammation (P<0. 05).
Conclusion: The incidences of tissue inflammation were high in both BPH and PCa, but the pathological features of tissue inflammation were different between BPH and PCa.
Similar articles
-
[Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].Zhonghua Nan Ke Xue. 2007 Aug;13(8):685-9. Zhonghua Nan Ke Xue. 2007. PMID: 17918704 Chinese.
-
Oxidative stress and body composition in prostate cancer and benign prostatic hyperplasia patients.Anticancer Res. 2014 Sep;34(9):5051-6. Anticancer Res. 2014. PMID: 25202090
-
[PSA testing, biopsy and cancer and benign prostate hyperplasia in France].Prog Urol. 2014 Jul;24(9):572-80. doi: 10.1016/j.purol.2014.03.004. Epub 2014 Apr 16. Prog Urol. 2014. PMID: 24975792 French.
-
The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.Eur Urol. 2011 Jul;60(1):106-17. doi: 10.1016/j.eururo.2011.03.055. Epub 2011 Apr 9. Eur Urol. 2011. PMID: 21497433 Review.
-
Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review.Eur Urol. 2009 Apr;55(4):864-73. doi: 10.1016/j.eururo.2008.11.011. Epub 2008 Nov 21. Eur Urol. 2009. PMID: 19027219 Review.
Cited by
-
Specific expression pattern of tissue cytokines analyzed through the Surface Acoustic Wave technique is associated with age-related spontaneous benign prostatic hyperplasia in rats.Biochem Biophys Rep. 2018 Apr 2;14:26-34. doi: 10.1016/j.bbrep.2018.03.005. eCollection 2018 Jul. Biochem Biophys Rep. 2018. PMID: 29872731 Free PMC article.
-
The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer.Int J Med Sci. 2015 Oct 15;12(11):853-61. doi: 10.7150/ijms.11713. eCollection 2015. Int J Med Sci. 2015. PMID: 26640404 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical